The DOI matches its Crossref record.
Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment
Abstract
The objective of the present study was to assess the toxicology of melatonin (10 mg), administered for 28 days to 40 volunteers randomly assigned to groups receiving either melatonin (N=30) or placebo (N=10) in a double‐blind fashion. The following measurements were performed: polysomnography (PSG), laboratory examinations, including complete blood count, urinalysis, sodium, potassium and calcium levels, total protein levels, albumin, blood glucose, triglycerides, total cholesterol, high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), and very low‐density lipoprotein (VLDL), urea, creatinine, uric acid, glutamic‐oxalacetic transaminase (GOT), glutamic‐pyruvate transaminase (GPT), bilirubin, alkaline phosphatase, gama‐glutamic transaminase (GGT), T3, T4, TSH, LH/FSH, cortisol, and melatonin serum concentrations. In addition, the Epworth Somnolence Scale (ESS) and a sleep diary (SD) were also applied to the volunteers 1 wk before each PSG. In addition, the volunteers were asked about possible side effects (SE) that appeared during the treatment. The study was carried out according to the following timetable: Visit 0, filling out the term of consent and inclusion criteria; Visit 1, PSG, laboratory examinations, ESS, SD, melatonin serum concentrations; Visit 2, SD, melatonin serum concentrations, SE; Visit 3, melatonin serum concentrations, PSG, ESS, SE; Visit 4, laboratory examinations, SE, melatonin serum concentrations, SD; and Visit 5, PSG, ESS, SE. Analysis of the PSG showed a statistically significant reduction of stage 1 of sleep in the melatonin group. No other differences between the placebo and melatonin groups were obtained. In the present study we did not observe, according to the parameters analyzed, any toxicological effect that might compromise the use of melatonin at a dose of 10 mg for the period of time utilized in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Auger, R. R., Burgess, H. J., Emens, J. S., Deriy, L. V., Thomas, S. M., & Sharkey, K. M. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5100 · Cited by 438
Melatonin: reducing the toxicity and increasing the efficacy of drugs
Reiter, R. J., Tan, D.-X., Sainz, R. M., Mayo, J. C., & Lopez-Burillo, S. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760345374 · Cited by 417
Melatonin, human aging, and age-related diseases
Karasek, M. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.012 · Cited by 380
Dietary Sources and Bioactivities of Melatonin
Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R.-Y., Xu, D.-P., & Li, H.-B. (2017) · Nutrients · doi:10.3390/nu9040367 · Cited by 362
Melatonin: Action as antioxidant and potential applications in human disease and aging
Bonnefont-Rousselot, D., & Collin, F. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.008 · Cited by 320
Metadata
- Authors
- Seabra, M. D. L. V., Bignotto, M., Pinto Jr., L. R., & Tufik, S.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2000-11
- Volume
- 29
- Issue
- 4
- Pages
- 193-200
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2104511643
- Cited by
- 279
- References
- 0
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. https://app.cochat.ai/papers/10.1034/j.1600-0633.2002.290401.x
- The paper
- Seabra, M. D. L. V., Bignotto, M., Pinto Jr., L. R., & Tufik, S. (2000). Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. Journal of Pineal Research. https://doi.org/10.1034/j.1600-0633.2002.290401.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.